Alzheimer
Alzheimer’s Medication
A clear guide to Alzheimer's medication: anti-amyloid infusions, cholinesterase inhibitors, memantine and drugs for sleep or agitation, plus their side effects.
Read article →LATEST NEWS
FDA & Drugs
FDA approvals, safety reviews, recalls and what new medications mean in practice. Our coverage explains the evidence behind each decision and the questions worth asking a doctor or pharmacist.
Consumer Health
A New Sunscreen Ingredient Reaches U.S. Shelves After a Long FDA Review
Bemotrizinol is the first new U.S. sunscreen active ingredient in more than two decades, arriving as skin-cancer prevention remains a public health priority.
Read article →
Diabetes Care
Medicare open enrollment starts with bigger drug-cost changes ahead
Medicare’s open enrollment season is under way, and several policy changes scheduled for 2027 could affect drug costs, plan choices and access to widely used diabetes and weight-loss medicines.
Read article →
Artificial Intelligence
FDA maps out next wave of AI oversight for medical devices
The FDA’s new fiscal 2027 guidance list shows that artificial intelligence will remain a major focus, with planned documents on AI-enabled device software, generative AI, and related evidence standards.
Read article →
Compounding Pharmacies
FDA Peptide Review Could Ease Access, but Safety Questions Remain
Federal advisers have opened the door to temporary access for several unapproved peptide products, even as FDA warnings continue to stress that compounded versions are not reviewed for safety, effectiveness or quality.
Read article →
Abortion Pill
FDA mifepristone review stretches into 2027 as debate continues
The FDA says its ongoing safety review of mifepristone will continue into next year, keeping one of the nation’s most closely watched drug-policy fights in motion.
Read article →
Family Caregiving
Long-Term Care Medication Risks That Deserve a Second Look
AARP’s latest caregiving guidance highlights why medication lists in long-term care need regular review—especially for drugs linked to confusion, falls, and other side effects.
Read article →
Abortion Pill
FDA review of abortion pill safety will stretch into 2027
The FDA says its safety review of mifepristone will continue into next year, keeping attention on a drug that is widely used for abortion and miscarriage care.
Read article →
Cyclospora
FDA Links Cyclospora Outbreak to Mexican Lettuce Farm
Federal investigators say they found Cyclospora at a Mexican farm tied to a 2026 lettuce outbreak, adding clarity to a food safety probe that matters for older adults.
Read article →Health
Tinnitus and NSAIDs: Medication Review Questions
NSAIDs can be associated with tinnitus for some people, especially at higher doses. Ask a clinician before changing medicines. Learn targeted evaluation steps, practical coping options, and why supplement marketing is not proof of…
Read article →Health
Tinnitus and Antidepressants: Do Not Stop Medication Abruptly
Tinnitus can emerge while using antidepressants, but do not stop abruptly. Seek clinician guidance, rule out urgent causes, consider sound support and CBT, and review options safely. Supplements are marketed but lack proof for…
Read article →Health
Tinnitus Supplements and Drug Interactions: A Safety Guide
Learn how tinnitus supplements can interact with common medicines, what to ask your clinician, safer non-pill options, and why product marketing isn’t proof of tinnitus benefit.
Read article →